J0897 Denosumab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Denosumab

Brand Name:

Prolia

Strength:

1 mg

HCPCS:

J0897

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

RANKL

Oral (Y/N):

No

FDA Approval Year:

2010

FDA Discontinuation Year:

CMS Effective Date:

Oct. 1, 2012

CMS Discontinuation Date:

Status:

In Use